Singapore: Q1 profits slump at Raffles Medical

First quarter profits have slumped at Raffles Medical Group (RMG), the largest private medical group practice in Singapore, thanks to startup costs in China. Profits...

Singapore: Staff costs depress first half profits at AHS

For the first half of the year, profits at Asian Healthcare Specialists (AHS) declined as the orthopaedic specialists focused on its talent pool, and...

Australia: Saluda Medical raises debt funding from Medronic

New South Wales-based Saluda Medical has secured a four-year term loan agreement with Medtronic, to fund continued development of its spinal cord medical device....

UAE: NMC Healthcare signs US$80m Murabaha facility

NMC Healthcare, the largest healthcare provider in the United Arab Emirates, has signed a US$80m one-year revolving syndicated Murabaha facility. The facility will be utilised...

China: JD.com raises US$1bn Series A for healthcare subsidiary

Chinese e-commerce giant JD.com has raised US$1bn Series A funding for its healthcare subsidiary JD Health. It has sold a 14.5% stake to investors including...

Australia: Estia lowers earnings expectations

Shares in Estia Health plunged as much at 6% on Friday after the aged care operator lowered its full-year earnings expectations. The company said that...

Germany: Profits jump 24% at Siemens Healthineers

The Imaging and Advanced Therapies businesses have driven impressive Q2 results at the German health-tech business that beat expectations. Profits at Siemens Healthineers were up...

Kuwait: Mezzan creates diabetes distribution joint venture

Mezzan Holding has signed a healthcare distribution joint venture in Kuwait to focus primarily on diabetes products. The 51/49 joint venture will sell and distribute...

Medlife reports 46% drop in Q1 figures

Despite a jump in sale, Romania’s largest private medical operator, Medlife, has reported a slump in first quarter profits. Thanks to an increase in foreign...

Luxembourg: Vesalius Biocapital III closes at €120m

Specialist life sciences venture capital investor Vesalius Biocapital has closed Vesalius Biocapital III at €120m (US$136.5m). This includes commitments of €30m from the European...